We are live on
!
Find out more
SI
Scharf Investments Portfolio holdings
AUM
$3.03B
1-Year Est. Return
7.75%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
+7.75%
3 Year Est. Return
+55.03%
5 Year Est. Return
+80.17%
10 Year Est. Return
+289.59%
AUM
$2.12B
AUM Growth
+$272M
(+15%)
Cap. Flow
+$97.8M
Cap. Flow
% of AUM
4.62%
Top 10 Holdings %
Top 10 Hldgs %
46.05%
Holding
43
New
4
Increased
17
Reduced
9
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$89.9M |
| 2 |
Oil States International
OIS
|
+$46.7M |
| 3 |
Sanofi
SNY
|
+$21M |
| 4 |
Markel Group
MKL
|
+$6.38M |
| 5 |
Apple
AAPL
|
+$4.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$45.7M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$15.5M |
| 3 |
Baidu
BIDU
|
+$13.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$9.47M |
| 5 |
Lockheed Martin
LMT
|
+$8.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.23% |
| 2 | Technology | 22.27% |
| 3 | Energy | 17.75% |
| 4 | Financials | 13.17% |
| 5 | Communication Services | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Thermo Fisher Scientific
TMO
$214B
| $36.5M | 1.72% |
395,827
-104,749
| -21% | -$9.47M |
|
|
27
Markel Group
MKL
$23.4B
| $6.28M | 0.3% |
+12,135
| New | +$6.38M |
|
28
WisdomTree Japan Hedged Equity Fund
DXJ
$7.13B
| $2.77M | 0.13% |
57,783
| – | – |
|
29
SLB Ltd
SLB
$72.6B
| $1.1M | 0.05% |
12,400
| – | – |
|
30
IBM
IBM
$209B
| $1M | 0.05% |
5,653
+1,256
| +29% | +$228K |
|
31
Walt Disney
DIS
$167B
| $946K | 0.04% |
14,675
| – | – |
|
32
GE Aerospace
GE
$368B
| $929K | 0.04% |
8,115
| – | – |
|
33
Canadian National Railway
CNI
$76.9B
| $892K | 0.04% |
17,594
| – | – |
|
34
McDonald's
MCD
$191B
| $646K | 0.03% |
6,711
| – | – |
|
35
Suncor Energy
SU
$78.8B
| $532K | 0.03% |
14,880
-2,400
| -14% | -$79.8K |
|
36
Loews
L
$23.9B
| $421K | 0.02% |
9,013
| – | – |
|
|
37
VanEck Gold Miners ETF
GDX
$23.5B
| – | – |
-631,005
| Closed | -$15.5M |
|
|
B
38
Barrick Mining
B
$63.2B
| – | – |
-108,572
| Closed | -$1.71M |
|
39
GSK
GSK
$104B
| – | – |
-7,564
| Closed | -$472K |
|
|
PPLT
40
abrdn Physical Platinum Shares ETF
PPLT
$1.89B
| – | – |
-53,500
| Closed | -$701K |
|
41
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| – | – |
-9,551
| Closed | -$1.53M |
|
|
42
Tapestry
TPR
$30.8B
| – | – |
-800,468
| Closed | -$45.7M |
|
Similar funds
MCM
CM
JIC
MB
CFM
SM
TAM
KIA
Scharf Investments's Q3 2013 Portfolio in Review
As of Q3 2013, Scharf Investments held 43 positions worth $2.12B, up 15% from $1.84B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Scharf Investments deployed $97.8M of net new capital in Q3 2013, opening 4 new positions and adding to 17 existing holdings. Its largest new stake was Allergan Inc: 1,001,250 shares worth $90.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Baidu, an estimated $13.7M trimmed.
- Scharf Investments's largest Q3 2013 buy was Allergan Inc: 1,001,250 shares worth $90.6M.
- Scharf Investments added most to Sanofi in Q3 2013, an estimated $21M increase.
- Scharf Investments's biggest Q3 2013 reduction was Baidu, cutting an estimated $13.7M.
- Scharf Investments fully exited Tapestry in Q3 2013, selling an estimated $45.7M.
- Scharf Investments's ten largest holdings make up 46% of its $2.12B portfolio in Q3 2013.
- Scharf Investments opened 4 new positions and closed 6 in Q3 2013.
- Scharf Investments's portfolio value rose 15% quarter-over-quarter to $2.12B.
Based on Scharf Investments's 13F filing for Q3 2013, filed 14 Nov 2013.